Clinical trial
TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients
NCT00289809 · Istituto Clinico Humanitas, Other · Completed
Key facts
| NCT number | NCT00289809 |
|---|---|
| Title | TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients |
| Official title | A Perspective Phase I and II Trial of Liposome-encapsulated Doxorubicin (TLC D-99) in Combination With Ifosfamide in Patients With Metastatic Soft Tissue Sarcoma |
| Lead sponsor | Istituto Clinico Humanitas, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma, Soft Tissue |
| Intervention type | Drug |
| Interventions | combination of TLC D-99 and Ifosfamide |
| Enrollment | 36 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Feb 10, 2006 |
| Last update posted | Dec 18, 2009 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: